Eileen Carry

Zena Therapeutics Inc.

NIH Rank #53718
  • Early Career

NIH Funding · FY2024

Total Funding
$55K
Fiscal year 2024
Grants Awarded
1
Active NIH grants
National Rank
#53,718
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $55K across 1 grant · National rank #53718.

Top grants by award amount

Eileen Carry's NIH grant portfolio, ranked by award amount.

  • 3R41DA058472-01S1R41
    Development of compound RUEC2-118, a novel partial GABAAR positive modulator, a fast-acting treatment for general anxiety and panic disorder, to prevent opioid and benzodiazepine overdose fatalities.
    $55K
    award amount

Affiliation

Institutions that have administered grants for Eileen Carry.

Affiliated with Zena Therapeutics Inc. (NJ).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Zena Therapeutics Inc.